US Approves Drug to Prevent Sickle Cell Pain, Organ Damage
U.S. regulators on Friday approved a new medicine that can prevent some extremely painful sickle cell disease flare-ups. The Food and Drug Administration approved Novartis AG’s Adakveo for patients 16 and older. The monthly infusion, which halves occurrences of sickle cell pain episodes, will carry a list price of roughly …